Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
CervoMed Inc. (CRVO) had Stock-Based Compensation of $0.71M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-6.57M |
|
-- |
|
-- |
|
$6.68M |
|
$-6.68M |
|
$0.11M |
|
$-6.57M |
|
$-6.57M |
|
$-6.57M |
|
$-6.57M |
|
$-6.57M |
|
$-6.57M |
|
$-6.68M |
|
$-6.68M |
|
10.24M |
|
10.24M |
|
$-0.64 |
|
$-0.64 |
|
| Balance Sheet Financials | |
$25.99M |
|
-- |
|
-- |
|
$25.99M |
|
$3.03M |
|
-- |
|
-- |
|
$3.03M |
|
$22.96M |
|
$22.96M |
|
$22.96M |
|
13.53M |
|
| Cash Flow Statement Financials | |
$-14.94M |
|
$10.24M |
|
$18.93M |
|
$8.24M |
|
$22.46M |
|
$14.23M |
|
|
Stock-Based Compensation |
$0.71M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.57 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.94M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-28.62% |
|
-28.62% |
|
-25.28% |
|
-28.62% |
|
$1.70 |
|
$-1.46 |
|
$-1.46 |
|